Used in peptide synthesis, particularly in the development of modified bioactive peptides where enhanced metabolic stability and receptor selectivity are required. The 1-methyl modification on the tryptophan indole ring reduces oxidation and improves pharmacokinetic properties. Fmoc-Trp(1-Me)-OH is compatible with standard solid-phase peptide synthesis (SPPS) protocols, allowing for easy incorporation into peptide chains. It is especially valuable in research targeting G-protein coupled receptors (GPCRs), such as serotonin and melatonin receptors, due to the structural influence of the methylated indole. Also employed in the production of peptide-based pharmaceuticals and probes for biochemical studies.